| Funding Opportunity ID: |
333436 |
| Opportunity Number: |
W81XWH-21-MSRP-CTA |
| Opportunity Title: |
DOD Multiple Sclerosis Clinical Trial Award |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement
Grant |
| Category of Funding Activity: |
Science and Technology and other Research and Development |
| Category Explanation: |
|
| CFDA Number(s): |
12.420 |
| Eligible Applicants: |
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
|
| Agency Code: |
DOD-AMRAA |
| Agency Name: |
Department of Defense
Dept. of the Army — USAMRAA |
| Posted Date: |
May 10, 2021 |
| Close Date: |
Oct 01, 2021 |
| Last Updated Date: |
May 10, 2021 |
| Award Ceiling: |
$0 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
$8,000,000 |
| Expected Number of Awards: |
3 |
| Description: |
The MSRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, phase 0), to demonstrate feasibility or inform the design of more advanced trials, through larger-scale phase 1 or phase 2 trials to determine safety or efficacy in relevant patient populations. |
| Version: |
1 |
|
